Growth trajectory Exosens group and Xenics show sustained revenue growth in 2026 with first-half revenue up 15.3 percent to €253.1 million, signaling expanding demand for high-end imaging and infrared solutions that sales teams can leverage when targeting defense, industrial, and medical applications.

Strategic acquisitions Recent acquisitions, including Emberion and related asset sales, position Exosens to broaden infrared sensing capabilities and product breadth, creating cross-sell opportunities across cameras, detectors, and imaging cores for existing customers and new verticals.

Key defense contracts New major contract with Brolis Defence to supply approximately 17,000 high-performance image intensifier tubes for the Czech Armed Forces through 2032 highlights a robust, long-term government demand channel for image intensifier technology and related systems.

Strategic financing A substantial financing facility from the European Investment Bank and recent capital infusions improve liquidity and enable scale-up in manufacturing, R&D, and international sales coverage, supporting larger deal sizes and faster delivery to customers.

Global manufacturing footprint Partnerships with Photonis Defense for U.S. manufacturing and testing of BiNOD systems, combined with a European vendor base and worldwide sales network, creates near-term opportunities for localized programs, faster time-to-market, and regional service offerings for customers.